MyJournals Home  

RSS FeedsIbrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties (Bone Marrow Transplantation)

 
 

5 may 2018 12:00:03

 
Ibrutinib for bridging to allogeneic hematopoietic cell transplantation in patients with chronic lymphocytic leukemia or mantle cell lymphoma: a study by the EBMT Chronic Malignancies and Lymphoma Working Parties (Bone Marrow Transplantation)
 




 
129 viewsCategory: Medicine, Pathology
 
Circulating monocyte subsets in human chronic graft-versus-host disease (Bone Marrow Transplantation)
How to define and measure thymopoiesis after transplantation? (Bone Marrow Transplantation)
 
 
blog comments powered by Disqus


MyJournals.org
The latest issues of all your favorite science journals on one page

Username:
Password:

Register | Retrieve

Search:

Pathology


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures News Tweets Nachrichten